Patent · US Active

Crystal structure of CRIg and C3b:CRIg complex

US7930109B2 · kind B2 · utility

1Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 14, 2009
Grant dateApr 19, 2011
Priority date
Expiry dateDec 14, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2299/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention concerns determination of the crystal structure of the macrophage specific receptor, CRIg (earlier referred to as STIgMA), and its complex with the C3b and C3c subunits of complement C3 (C3b:CRIg and C3c:CRIg complexes). The invention further concerns the use of the crystal structure of CRIg or the C3b:CRIg complex to screen for and identify molecules structurally and/or functionally related to CRIg, including CRIg agonists and antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.